Molecular landscape and subtype-specific therapeutic response of nasopharyngeal carcinoma revealed by integrative pharmacogenomics
Nasopharyngeal carcinoma (NPC) is a malignant cancer type with high morbidity in Asia, and its current molecular classification is insufficient to predict therapy outcomes. Here the authors explore NPC subtype-specific response to therapy with a pharmacogenomics strategy integrating genomics and dru...
Guardado en:
Autores principales: | Ren-Bo Ding, Ping Chen, Barani Kumar Rajendran, Xueying Lyu, Haitao Wang, Jiaolin Bao, Jianming Zeng, Wenhui Hao, Heng Sun, Ada Hang-Heng Wong, Monica Vishnu Valecha, Eun Ju Yang, Sek Man Su, Tak Kan Choi, Shuiming Liu, Kin Iong Chan, Ling-Lin Yang, Jingbo Wu, Kai Miao, Qiang Chen, Joong Sup Shim, Xiaoling Xu, Chu-Xia Deng |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/87f829886bef4facb841e43c9c543db3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
NOTCH1 activation compensates BRCA1 deficiency and promotes triple-negative breast cancer formation
por: Kai Miao, et al.
Publicado: (2020) -
The pharmacogenomics journal
Publicado: (2001) -
Pharmacogenomics and Personalized Medicine
Publicado: (2009) -
Chapter 7: Pharmacogenomics.
por: Konrad J Karczewski, et al.
Publicado: (2012) -
Pharmacogenomics of hyaluronic acid
por: Elena E. Vaiman, et al.
Publicado: (2021)